- Sector
- Consumer durables
- Industry
- Homebuilding
- Address
- Singapore Singapore
- IPO Date
- Jul 5, 2010
- Business
- Alset International Limited is a Singapore-based diversified investment holding company engaged in property development, biomedical science, information technology, direct selling, and corporate investment activities. The company operates across five primary business segments: Property Development, Biomedical, Information Technology, Direct Selling, and Investment. Its Property Development segment focuses on land acquisition, master-planned residential community development, and the construction of sustainable smart living residences equipped with clean energy infrastructure, solar power systems, and smart home automation technologies across key metropolitan areas in the United States, including Texas and Maryland; its Biomedical segment specializes in the research, development, licensing, and commercialization of holistic health supplements, nutraceuticals, natural personal care formulations, and proprietary antiviral and antimicrobial products; its Information Technology segment delivers enterprise digital solutions, custom software engineering, cloud integration, e-commerce application development, and digital marketing services; its Direct Selling segment oversees international multi-channel direct distribution networks and digital commerce platforms for wellness, beauty, and nutritional consumer goods; and its Investment segment manages strategic equity portfolios, venture capital allocations, and corporate incubation investments targeting clean technology, sustainable infrastructure, and digital assets. Incorporated in 2009 and headquartered in Singapore, the company maintains operations spanning North America, the Asia-Pacific region, and Europe, operating as a subsidiary of United States-listed Alset Inc. In recent major developments, Alset International Limited has expanded its sustainable smart home residential pipeline in the United States, broadened its strategic collaborations in renewable energy and clean mobility integration for master-planned communities, realigned its international direct-to-consumer wellness distribution channels, and optimized its corporate capital structure through strategic portfolio realignments and targeted asset divestments to prioritize high-growth property and biotechnology initiatives.